Purchase Order 75D30123P15841

Toxicologic Pathology Associates Inc. was awarded a $20.7 million definitive contract by the Department of Health and Human Services' Food and Drug Administration to provide onsite pathology services from July 2015 through July 2020. The contract has a small business set aside designation. As part of its mission to protect public health, the FDA utilizes pathology expertise to evaluate samples for issues impacting medical products and the safety of the food supply. This award draws on the...

The U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR) awarded a $26,146,456.95 Definitive Contract to Toxicologic Pathology Associates Inc., a for-profit organization based in Frederick, Maryland, to provide comprehensive on-site pathology services for animal research. The contract is a Labor Hours (LH) type with a base period and up to four additional 1-year option periods, supporting NCTR's internationally recognized toxicological research activities that...

Toxicologic Pathology Associates Inc. (UEI: PMMBWH3UHBV7) was awarded a definitive contract by the Food and Drug Administration (FDA) on July 14, 2020, to provide on-site pathology services. This labor-hours contract, designated as a Total Small Business set-aside, carries a ceiling value of $24.58 million and is slated for completion by September 15, 2025. The services will be performed at the FDA facility located in Jefferson, Arkansas. Pathology services of this nature typically support the...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order valued at $803,683.20 to Experimental Pathology Laboratories, Inc. (EPL), a Sterling, Virginia-based contract research organization specializing in toxicology and pathology services. This unrestricted procurement, awarded on September 25, 2024, with completion targeted for September 24, 2027, provides histopathology services to support small animal product efficacy studies focused on...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $498,315 firm fixed price contract to Integrated Laboratory Systems, LLC for histopathology services. The contract supports the Division of Microbiology and Infectious Diseases' ongoing animal efficacy studies of SARS-CoV-2 vaccines and therapeutics by providing veterinary pathology evaluation, interpretation, imaging and reporting of prepared tissue slides. Per the solicitation, the contractor...

The Environmental Protection Agency Office of Research and Development awarded a $25,220.60 firm fixed-price purchase order contract to Experimental Pathology Laboratories, Inc. (EPL) for histology and pathology services on a post-natal rodent liver and kidney study. This award is related to a previous EPA-funded study and will cover the histopathological examination of up to 200 rodent specimens. EPL is a privately held, employee-owned contract research organization that provides specialized...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract for $11,430.96 to Experimental Pathology Laboratories, Inc. (EPL) for pathology services. The contract has a completion date of May 31, 2024 and does not have a set-aside designation. EPL is a for-profit, Subchapter S corporation that provides a comprehensive range of toxicology pathology services to federal agencies such as the Environmental Protection...

This federal contract award, valued at $28,290.26, was issued by the U.S. Environmental Protection Agency's Office of Research and Development to Experimental Pathology Laboratories, Inc. (EPL), a for-profit Subchapter S corporation specializing in toxicology pathology services. The contract is for analysis and reporting of histology and pathology of rodent tissues following exposure to per- and polyfluoroalkyl substances (PFAS) in multiple samples of adult livers and kidneys, as well as pop...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $35,860.00 firm fixed price purchase order contract to Inotiv, Inc., a for-profit contract research organization, for the pathology evaluation of mice lungs. The contract has an ultimate completion date of April 22, 2025 and was awarded on June 11, 2024. It is not a set-aside contract. Inotiv, Inc. is a well-established company that provides a wide range of scientific research and testing services to federal agencies,...

This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization. The $12,650 contract is for microscopic evaluation of mouse tissue slides obtained from mice exposed to peroxyacetic acid aerosol. The contract does not have a set-aside designation, indicating EPL competed in an open federal procurement process. EPL has a long history of...